Cecilia Furlong
Stock Analyst at Morgan Stanley
(0.28)
# 3,260
Out of 4,667 analysts
185
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $3.76 | +32.98% | 15 | Nov 11, 2024 | |
| ISRG Intuitive Surgical | Maintains: Equal-Weight | $460 → $475 | $550.62 | -13.73% | 12 | Jul 19, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.00 | -14.29% | 12 | Jul 15, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $14 → $9 | $4.36 | +106.42% | 8 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $73.90 | +75.91% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $108.40 | +10.70% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $79.34 | +19.74% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $84.74 | +15.65% | 9 | Nov 22, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $49.75 | +66.83% | 10 | Aug 3, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $85.57 | -0.67% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $15 | $28.03 | -46.49% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $262.00 | +30.92% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $6.42 | +118.07% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $32.99 | +45.50% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $70.38 | +44.93% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $91.50 | -36.61% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $19.81 | +0.96% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $74.46 | +75.93% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $117.26 | +13.42% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $390.14 | -43.61% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $190.64 | +98.28% | 2 | Feb 25, 2022 |
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.76
Upside: +32.98%
Intuitive Surgical
Jul 19, 2024
Maintains: Equal-Weight
Price Target: $460 → $475
Current: $550.62
Upside: -13.73%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.00
Upside: -14.29%
Nevro
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $14 → $9
Current: $4.36
Upside: +106.42%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $73.90
Upside: +75.91%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $108.40
Upside: +10.70%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $79.34
Upside: +19.74%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $84.74
Upside: +15.65%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $49.75
Upside: +66.83%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $85.57
Upside: -0.67%
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $28.03
Upside: -46.49%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $262.00
Upside: +30.92%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.42
Upside: +118.07%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $32.99
Upside: +45.50%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $70.38
Upside: +44.93%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $91.50
Upside: -36.61%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $19.81
Upside: +0.96%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $74.46
Upside: +75.93%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $117.26
Upside: +13.42%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $390.14
Upside: -43.61%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $190.64
Upside: +98.28%